The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Shy-Drager Syndrome

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Shy-Drager Syndrome


High impact information on Shy-Drager Syndrome


Chemical compound and disease context of Shy-Drager Syndrome


Biological context of Shy-Drager Syndrome


Anatomical context of Shy-Drager Syndrome


Gene context of Shy-Drager Syndrome


  1. Effect of the somatostatin analogue SMS-201-995 on the adrenergic response to glucose ingestion in patients with postprandial hypotension. Hoeldtke, R.D., Dworkin, G.E., Gaspar, S.R., Israel, B.C., Boden, G. Am. J. Med. (1989) [Pubmed]
  2. Treatment of orthostatic hypotension with octreotide. Hoeldtke, R.D., Israel, B.C. J. Clin. Endocrinol. Metab. (1989) [Pubmed]
  3. Midodrine. A new agent in the management of idiopathic orthostatic hypotension and Shy-Drager syndrome. Schirger, A., Sheps, S.G., Thomas, J.E., Fealey, R.D. Mayo Clin. Proc. (1981) [Pubmed]
  4. Blood pressure responses to noradrenaline and dopamine infusions in Parkinson's disease and the Shy-Drager syndrome. Wilcox, C.S., Aminoff, M.J. British journal of clinical pharmacology. (1976) [Pubmed]
  5. Expression of the histocompatibility glycoprotein HLA-DR in neurological disease. McGeer, P.L., Itagaki, S., McGeer, E.G. Acta Neuropathol. (1988) [Pubmed]
  6. Effect of xamoterol in Shy-Drager syndrome. Obara, A., Yamashita, H., Onodera, S., Yahara, O., Honda, H., Hasebe, N. Circulation (1992) [Pubmed]
  7. Blood pressure and vasopressin in progressive autonomic failure. Response to postural stimulation, L-dopa and naloxone. Puritz, R., Lightman, S.L., Wilcox, C.S., Forsling, M., Bannister, R. Brain (1983) [Pubmed]
  8. Autonomic hyperreflexia in pure progressive autonomic failure: a case report. Mitsui, T., Kawai, H., Taguchi, E., Miyamoto, H., Saito, S. Neurology (1993) [Pubmed]
  9. Monoamine oxidase inhibitors and Sinemet in Shy-Drager syndrome. Rae-Grant, A., Young, G.B., Spence, J.D. Neurology (1985) [Pubmed]
  10. Shy-Drager syndrome with abnormal respirations and antidiuretic hormone release. Lockwood, A.H. Arch. Neurol. (1976) [Pubmed]
  11. The use of lisuride in the treatment of multiple system atrophy with autonomic failure (Shy-Drager syndrome). Lees, A.J., Bannister, R. J. Neurol. Neurosurg. Psychiatr. (1981) [Pubmed]
  12. Vasopressin secretion in progressive autonomic failure: evidence for defective afferent cardiovascular pathways. Williams, T.D., Lightman, S.L., Bannister, R. J. Neurol. Neurosurg. Psychiatr. (1985) [Pubmed]
  13. The management of Shy-Drager syndrome with propantheline and intermittent self-catheterization: a case report. Wulfsohn, M.A., Rubenstein, A. J. Urol. (1981) [Pubmed]
  14. Indomethacin and propranolol combined treatment for Shy-Drager syndrome. Galassi, G. J. Neurol. Neurosurg. Psychiatr. (1982) [Pubmed]
  15. Urological aspects of the Shy-Drager syndrome: a urodynamic and telemetric investigation. Incontinence treatment by electrical pacemaker and prenalterol. Vereecken, R.L., Goovaerts, J., Knockaert, D., Joossens, J., Sansen, W. Eur. Urol. (1985) [Pubmed]
  16. Multiple system atrophy. Kulczycki, J. Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences. (1997) [Pubmed]
  17. Tuberoinfundibular dopaminergic system and anterior pituitary dopamine receptor in Shy-Drager syndrome. Konagaya, Y., Konagaya, M., Takayanagi, T. J. Neurol. Sci. (1985) [Pubmed]
  18. Catechol-o-methyltransferase and blood pressure in humans. Jordan, J., Lipp, A., Tank, J., Schröder, C., Stoffels, M., Franke, G., Diedrich, A., Arnold, G., Goldstein, D.S., Sharma, A.M., Luft, F.C. Circulation (2002) [Pubmed]
  19. Postural changes in plasma renin activity and responses to vasoactive drugs in a case of Shy-Drager syndrome. Mathias, C.J., Matthews, W.B., Spalding, J.M. J. Neurol. Neurosurg. Psychiatr. (1977) [Pubmed]
  20. Hemodynamic effects of lysine-vasopressin in orthostatic hypotension. Kochar, M.S. Am. J. Kidney Dis. (1985) [Pubmed]
  21. Intra-axonal corpora amylacea in the CNS. Takahashi, K., Iwata, K., Nakamura, H. Acta Neuropathol. (1977) [Pubmed]
WikiGenes - Universities